Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02501941 · ClinicalTrials.gov registry record · Phase 1
Spreading Depolarization and Ketamine Suppression
A Phase 1 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT02501941 is a Phase 1 study that has completed, run by University of New Mexico. The registered enrollment target is 10 participants.
The verdict
NCT02501941, a Phase 1 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Hypothesis: Cortical spreading depolarizations are inhibited by the NMDA receptor antagonist Ketamine Aim 1: To demonstrate, in a group of patients with acute severe brain injury requiring surgery including traumatic brain injury and aneurysmal subarachnoid hemorrhage, whether use of continuous infusion of ketamine decreases frequency of occurrence of cortical spreading depolarizations.
Interventions
- DRUG ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-05-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02501941
The ClinicalTrials.gov registry entry for NCT02501941 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ketamine is the first listed.
NCT02501941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02501941 about?
NCT02501941 is a clinical study titled "Spreading Depolarization and Ketamine Suppression". Hypothesis: Cortical spreading depolarizations are inhibited by the NMDA receptor antagonist Ketamine Aim 1: To demonstrate, in a group of patients with acute severe brain injury requiring surgery including traumatic brain injury and aneurysmal subarachnoid hemorrhage, whether use of continuous infu...
What is the current status of trial NCT02501941?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2015-07. Estimated completion is 2017-05-01.
What interventions are being tested in trial NCT02501941?
The interventions under investigation include: ketamine (DRUG).
Who is sponsoring clinical trial NCT02501941?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.